0001214659-23-016097.txt : 20231206
0001214659-23-016097.hdr.sgml : 20231206
20231206170141
ACCESSION NUMBER: 0001214659-23-016097
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231116
FILED AS OF DATE: 20231206
DATE AS OF CHANGE: 20231206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krogulski Kenneth
CENTRAL INDEX KEY: 0001695580
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 231470365
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE, SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4/A
1
marketforms-63722.xml
PRIMARY DOCUMENT
X0508
4/A
2023-11-16
2023-11-30
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001695580
Krogulski Kenneth
1600 WEST END AVE., SUITE 1300
NASHVILLE
TN
37203
true
false
false
false
1
Common Stock
2023-11-16
5
L
false
E
66
1.73
A
227925
D
Common Stock
2023-11-17
5
L
false
E
280
1.83
A
228205
D
Common Stock
2023-11-20
5
L
false
E
268
1.70
A
228473
D
Common Stock
2023-11-21
5
L
false
E
125
1.76
A
228598
D
Common Stock
2023-11-22
5
L
false
E
280
1.74
A
228878
D
Common Stock
2023-11-27
5
L
false
E
379
1.86
A
229257
D
Common Stock
2023-11-28
5
L
false
E
124
1.68
A
229381
D
Common Stock
2023-11-29
5
L
false
E
165
1.73
A
229546
D
Common Stock
2023-11-30
5
L
false
E
324
1.66
A
229870
D
The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023.
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
2023-12-06